TCI Wealth Advisors, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 125 filers reported holding CARA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.74 and the average weighting 0.6%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,580
+344.2%
729
+872.0%
0.00%
Q4 2022$806
-19.4%
750.0%0.00%
Q3 2022$1,0000.0%750.0%0.00%
Q2 2022$1,000
-75.0%
75
-75.9%
0.00%
-100.0%
Q1 2022$4,0000.0%3110.0%0.00%0.0%
Q4 2021$4,000
-20.0%
3110.0%0.00%0.0%
Q3 2021$5,000
+400.0%
311
+314.7%
0.00%
Q2 2021$1,000
-75.0%
75
-57.4%
0.00%
-100.0%
Q1 2021$4,000
+33.3%
176
+0.6%
0.00%
+100.0%
Q4 2020$3,000
+50.0%
1750.0%0.00%0.0%
Q3 2020$2,000
-33.3%
1750.0%0.00%0.0%
Q2 2020$3,000
+50.0%
1750.0%0.00%0.0%
Q1 2020$2,000
-33.3%
1750.0%0.00%0.0%
Q4 2019$3,0000.0%1750.0%0.00%0.0%
Q3 2019$3,000
-25.0%
1750.0%0.00%
-50.0%
Q2 2019$4,000
+33.3%
1750.0%0.00%
+100.0%
Q1 2019$3,000
+50.0%
1750.0%0.00%0.0%
Q4 2018$2,000
-50.0%
1750.0%0.00%
-50.0%
Q3 2018$4,000
+33.3%
1750.0%0.00%
+100.0%
Q2 2018$3,000
+50.0%
1750.0%0.00%0.0%
Q1 2018$2,0000.0%1750.0%0.00%0.0%
Q4 2017$2,0000.0%1750.0%0.00%0.0%
Q3 2017$2,000
+100.0%
175
+133.3%
0.00%0.0%
Q2 2017$1,0000.0%750.0%0.00%0.0%
Q1 2017$1,000750.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders